 Alison Bauer
Concepts (236)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinogenesis | 5 | 2020 | 177 | 2.040 |
Why?
| | Polycyclic Aromatic Hydrocarbons | 5 | 2021 | 24 | 1.940 |
Why?
| | Lung Neoplasms | 13 | 2018 | 2177 | 1.700 |
Why?
| | Butylated Hydroxytoluene | 7 | 2020 | 31 | 1.380 |
Why?
| | Carcinogens | 4 | 2017 | 103 | 1.280 |
Why?
| | Toll-Like Receptor 4 | 4 | 2016 | 287 | 1.240 |
Why?
| | Pneumonia | 8 | 2016 | 567 | 1.030 |
Why?
| | Lung | 11 | 2021 | 3558 | 0.970 |
Why?
| | Anthracenes | 4 | 2023 | 27 | 0.960 |
Why?
| | Ozone | 6 | 2011 | 99 | 0.950 |
Why?
| | Signal Transduction | 6 | 2019 | 4509 | 0.880 |
Why?
| | Lightning | 1 | 2023 | 2 | 0.870 |
Why?
| | Lightning Injuries | 1 | 2023 | 5 | 0.860 |
Why?
| | Mice, Inbred BALB C | 9 | 2020 | 1143 | 0.860 |
Why?
| | Methylcholanthrene | 3 | 2020 | 18 | 0.820 |
Why?
| | NF-E2-Related Factor 2 | 2 | 2013 | 71 | 0.780 |
Why?
| | Fluorenes | 2 | 2019 | 38 | 0.780 |
Why?
| | Sports | 1 | 2023 | 187 | 0.720 |
Why?
| | Genetic Predisposition to Disease | 8 | 2010 | 2084 | 0.700 |
Why?
| | Eicosanoids | 1 | 2019 | 54 | 0.640 |
Why?
| | Air Pollutants | 4 | 2020 | 242 | 0.630 |
Why?
| | Alveolar Epithelial Cells | 1 | 2019 | 93 | 0.610 |
Why?
| | Mucin 5AC | 1 | 2018 | 48 | 0.610 |
Why?
| | Inflammation | 5 | 2017 | 2477 | 0.580 |
Why?
| | Mice | 26 | 2021 | 14860 | 0.570 |
Why?
| | Mitogens | 1 | 2017 | 58 | 0.560 |
Why?
| | Benzene | 4 | 2005 | 13 | 0.550 |
Why?
| | Animals | 31 | 2021 | 31694 | 0.540 |
Why?
| | Epiregulin | 1 | 2016 | 2 | 0.530 |
Why?
| | Military Personnel | 1 | 2023 | 523 | 0.520 |
Why?
| | Acetylcysteine | 1 | 2016 | 141 | 0.500 |
Why?
| | Adenocarcinoma | 3 | 2016 | 795 | 0.490 |
Why?
| | Pulmonary Alveoli | 1 | 2017 | 373 | 0.480 |
Why?
| | Lung Diseases | 3 | 2017 | 701 | 0.460 |
Why?
| | Epithelial Cells | 6 | 2020 | 950 | 0.460 |
Why?
| | Tobacco Smoke Pollution | 1 | 2017 | 217 | 0.460 |
Why?
| | Gene Deletion | 2 | 2016 | 356 | 0.460 |
Why?
| | Nanotubes, Carbon | 3 | 2020 | 43 | 0.450 |
Why?
| | Gap Junctions | 4 | 2020 | 58 | 0.420 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2016 | 1141 | 0.420 |
Why?
| | Gene Expression Profiling | 4 | 2018 | 1518 | 0.410 |
Why?
| | Mitogen-Activated Protein Kinases | 4 | 2020 | 278 | 0.400 |
Why?
| | Connexin 43 | 3 | 2017 | 23 | 0.400 |
Why?
| | Urethane | 2 | 2011 | 41 | 0.400 |
Why?
| | Ethanol | 1 | 2016 | 538 | 0.390 |
Why?
| | Cell Communication | 3 | 2020 | 279 | 0.380 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2011 | 61 | 0.370 |
Why?
| | Cell Line | 5 | 2020 | 2635 | 0.360 |
Why?
| | Enzyme Activation | 3 | 2019 | 785 | 0.360 |
Why?
| | Immunity, Innate | 1 | 2016 | 720 | 0.360 |
Why?
| | Vanadium Compounds | 1 | 2010 | 1 | 0.350 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 961 | 0.350 |
Why?
| | Oxidative Stress | 1 | 2016 | 1076 | 0.350 |
Why?
| | Lung Injury | 2 | 2010 | 197 | 0.340 |
Why?
| | Air Pollution | 1 | 2010 | 169 | 0.300 |
Why?
| | Cyclooxygenase 2 | 2 | 2019 | 164 | 0.290 |
Why?
| | Dose-Response Relationship, Drug | 5 | 2019 | 1842 | 0.280 |
Why?
| | Molecular Weight | 2 | 2019 | 331 | 0.260 |
Why?
| | Hematologic Diseases | 2 | 2003 | 55 | 0.260 |
Why?
| | Bone Marrow Cells | 3 | 2003 | 267 | 0.260 |
Why?
| | Brain | 1 | 2016 | 2371 | 0.240 |
Why?
| | Quantitative Trait, Heritable | 2 | 2002 | 116 | 0.230 |
Why?
| | Epoxide Hydrolases | 2 | 2005 | 10 | 0.230 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 2 | 2005 | 31 | 0.230 |
Why?
| | DNA Damage | 3 | 2020 | 351 | 0.230 |
Why?
| | Mutation | 4 | 2018 | 3344 | 0.220 |
Why?
| | Heat Stress Disorders | 1 | 2023 | 40 | 0.210 |
Why?
| | Organophosphonates | 1 | 2023 | 90 | 0.200 |
Why?
| | Occupational Injuries | 1 | 2023 | 46 | 0.200 |
Why?
| | Chemokines | 2 | 2016 | 216 | 0.200 |
Why?
| | Phosphorylation | 2 | 2019 | 1569 | 0.200 |
Why?
| | Saccharum | 1 | 2023 | 59 | 0.200 |
Why?
| | Mice, Inbred Strains | 5 | 2014 | 396 | 0.200 |
Why?
| | Time Factors | 3 | 2019 | 6112 | 0.200 |
Why?
| | Macrophages | 2 | 2021 | 1261 | 0.190 |
Why?
| | Hot Temperature | 2 | 2023 | 302 | 0.190 |
Why?
| | Chromosome Mapping | 2 | 2002 | 487 | 0.190 |
Why?
| | Mast Cells | 2 | 2021 | 116 | 0.190 |
Why?
| | Benz(a)Anthracenes | 1 | 2021 | 2 | 0.190 |
Why?
| | Benzopyrenes | 1 | 2021 | 4 | 0.190 |
Why?
| | Nanofibers | 1 | 2020 | 19 | 0.180 |
Why?
| | Mustard Gas | 1 | 2021 | 117 | 0.170 |
Why?
| | Occupational Exposure | 1 | 2023 | 255 | 0.170 |
Why?
| | Chemical Warfare Agents | 1 | 2021 | 119 | 0.170 |
Why?
| | Electrocardiography | 1 | 2023 | 560 | 0.170 |
Why?
| | Athletes | 1 | 2023 | 328 | 0.170 |
Why?
| | Printing | 1 | 2019 | 4 | 0.170 |
Why?
| | Paper | 1 | 2019 | 8 | 0.170 |
Why?
| | Particulate Matter | 2 | 2019 | 185 | 0.160 |
Why?
| | Group IV Phospholipases A2 | 1 | 2019 | 45 | 0.160 |
Why?
| | Bronchi | 1 | 2020 | 231 | 0.160 |
Why?
| | Nitrogen | 1 | 2019 | 143 | 0.160 |
Why?
| | Inhalation Exposure | 3 | 2020 | 97 | 0.150 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 260 | 0.150 |
Why?
| | Cell Degranulation | 1 | 2018 | 39 | 0.150 |
Why?
| | Cytochrome P-450 CYP1B1 | 1 | 2017 | 5 | 0.150 |
Why?
| | Monocytes | 1 | 2021 | 502 | 0.150 |
Why?
| | Air Pollution, Indoor | 1 | 2019 | 108 | 0.150 |
Why?
| | DNA Adducts | 1 | 2017 | 15 | 0.150 |
Why?
| | Benzo(a)pyrene | 1 | 2017 | 7 | 0.150 |
Why?
| | Silver | 1 | 2018 | 27 | 0.150 |
Why?
| | Neoplasms, Experimental | 1 | 2018 | 151 | 0.150 |
Why?
| | Survival Analysis | 2 | 2018 | 1211 | 0.150 |
Why?
| | Environmental Monitoring | 1 | 2019 | 254 | 0.150 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 228 | 0.140 |
Why?
| | Male | 11 | 2023 | 55554 | 0.140 |
Why?
| | Humans | 15 | 2023 | 114623 | 0.140 |
Why?
| | Lipid Peroxides | 1 | 2016 | 9 | 0.130 |
Why?
| | Glutathione Peroxidase | 1 | 2016 | 41 | 0.130 |
Why?
| | Chick Embryo | 1 | 2016 | 122 | 0.130 |
Why?
| | Up-Regulation | 1 | 2019 | 807 | 0.130 |
Why?
| | Bronchoalveolar Lavage | 1 | 2016 | 84 | 0.130 |
Why?
| | Brain Chemistry | 1 | 2016 | 115 | 0.130 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 84 | 0.130 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 923 | 0.120 |
Why?
| | Climate Change | 1 | 2017 | 120 | 0.120 |
Why?
| | ErbB Receptors | 1 | 2018 | 554 | 0.120 |
Why?
| | Disease Models, Animal | 3 | 2010 | 3531 | 0.120 |
Why?
| | Environment | 1 | 2017 | 332 | 0.120 |
Why?
| | Bronchoalveolar Lavage Fluid | 3 | 2014 | 590 | 0.120 |
Why?
| | Glutathione | 1 | 2016 | 293 | 0.120 |
Why?
| | Particle Size | 3 | 2020 | 317 | 0.120 |
Why?
| | Allergens | 1 | 2018 | 413 | 0.120 |
Why?
| | Metabolomics | 1 | 2019 | 521 | 0.120 |
Why?
| | Withania | 1 | 2014 | 3 | 0.110 |
Why?
| | Cell Differentiation | 1 | 2021 | 1700 | 0.110 |
Why?
| | Heart Diseases | 1 | 2017 | 331 | 0.110 |
Why?
| | Environmental Exposure | 1 | 2017 | 372 | 0.110 |
Why?
| | Genomics | 1 | 2018 | 635 | 0.110 |
Why?
| | Fatty Acids | 1 | 2016 | 381 | 0.110 |
Why?
| | Kelch-Like ECH-Associated Protein 1 | 1 | 2013 | 8 | 0.110 |
Why?
| | Mice, Transgenic | 1 | 2018 | 1947 | 0.110 |
Why?
| | Inactivation, Metabolic | 2 | 2003 | 11 | 0.110 |
Why?
| | Blood-Brain Barrier | 1 | 2014 | 106 | 0.110 |
Why?
| | Cell Membrane | 1 | 2016 | 680 | 0.100 |
Why?
| | Biomarkers, Tumor | 1 | 2018 | 1040 | 0.100 |
Why?
| | Plant Extracts | 1 | 2014 | 154 | 0.100 |
Why?
| | Transcriptome | 1 | 2017 | 725 | 0.100 |
Why?
| | Cell Death | 1 | 2013 | 322 | 0.100 |
Why?
| | Gene Expression | 1 | 2016 | 1421 | 0.090 |
Why?
| | Species Specificity | 2 | 2010 | 542 | 0.090 |
Why?
| | Prognosis | 1 | 2018 | 3328 | 0.090 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2011 | 90 | 0.090 |
Why?
| | Mice, Inbred C57BL | 4 | 2021 | 4689 | 0.090 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2013 | 386 | 0.090 |
Why?
| | Mice, Inbred A | 1 | 2010 | 45 | 0.090 |
Why?
| | Genes, Neoplasm | 1 | 2009 | 20 | 0.090 |
Why?
| | Transcription Factor AP-1 | 2 | 2007 | 80 | 0.080 |
Why?
| | Surface Properties | 2 | 2020 | 387 | 0.080 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 797 | 0.080 |
Why?
| | Gene Expression Regulation | 1 | 2017 | 2319 | 0.080 |
Why?
| | Interleukin-10 | 1 | 2010 | 299 | 0.080 |
Why?
| | Protein Kinase Inhibitors | 1 | 2013 | 785 | 0.070 |
Why?
| | Scavenger Receptors, Class A | 1 | 2007 | 9 | 0.070 |
Why?
| | Micronucleus Tests | 2 | 2005 | 4 | 0.070 |
Why?
| | Cell Survival | 2 | 2020 | 1020 | 0.070 |
Why?
| | Cell Line, Tumor | 1 | 2013 | 2710 | 0.070 |
Why?
| | Cytochrome P-450 CYP2E1 | 2 | 2003 | 25 | 0.070 |
Why?
| | Oxidants | 1 | 2007 | 112 | 0.070 |
Why?
| | Microsomes, Liver | 2 | 2003 | 55 | 0.070 |
Why?
| | Neoplasm Staging | 1 | 2009 | 1167 | 0.070 |
Why?
| | Cyclins | 2 | 2003 | 78 | 0.070 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2003 | 107 | 0.060 |
Why?
| | Receptors, Immunologic | 1 | 2007 | 201 | 0.060 |
Why?
| | Cytokines | 2 | 2021 | 1840 | 0.060 |
Why?
| | RNA, Messenger | 4 | 2010 | 2552 | 0.060 |
Why?
| | NF-kappa B | 2 | 2007 | 638 | 0.060 |
Why?
| | Prostaglandins | 1 | 2005 | 77 | 0.060 |
Why?
| | Administration, Inhalation | 2 | 2003 | 641 | 0.060 |
Why?
| | Female | 4 | 2018 | 59466 | 0.060 |
Why?
| | Macrophages, Alveolar | 1 | 2007 | 347 | 0.060 |
Why?
| | Chronic Disease | 1 | 2009 | 1578 | 0.060 |
Why?
| | Mice, Knockout | 3 | 2007 | 2565 | 0.060 |
Why?
| | Bone Marrow | 1 | 2005 | 243 | 0.060 |
Why?
| | Mutagens | 1 | 2003 | 17 | 0.050 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2003 | 59 | 0.050 |
Why?
| | Disease Progression | 1 | 2009 | 2380 | 0.050 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2005 | 308 | 0.050 |
Why?
| | Models, Biological | 1 | 2009 | 1620 | 0.050 |
Why?
| | Reproducibility of Results | 1 | 2009 | 2762 | 0.050 |
Why?
| | Antineoplastic Agents | 1 | 2013 | 1879 | 0.050 |
Why?
| | Transcription Factors | 1 | 2010 | 1528 | 0.050 |
Why?
| | Lod Score | 1 | 2002 | 65 | 0.050 |
Why?
| | Hematopoietic Stem Cells | 1 | 2005 | 343 | 0.050 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2007 | 1139 | 0.050 |
Why?
| | Leukocytes | 1 | 2003 | 276 | 0.050 |
Why?
| | Mechlorethamine | 1 | 2021 | 63 | 0.050 |
Why?
| | Genetic Markers | 1 | 2002 | 320 | 0.050 |
Why?
| | Temperature | 1 | 2023 | 565 | 0.040 |
Why?
| | Nitric Oxide | 1 | 2005 | 823 | 0.040 |
Why?
| | Graphite | 1 | 2019 | 11 | 0.040 |
Why?
| | Metals | 1 | 2019 | 106 | 0.040 |
Why?
| | Dinitrobenzenes | 1 | 2018 | 6 | 0.040 |
Why?
| | Genetic Variation | 1 | 2003 | 870 | 0.040 |
Why?
| | Receptors, IgE | 1 | 2018 | 40 | 0.040 |
Why?
| | Lipids | 1 | 2021 | 580 | 0.040 |
Why?
| | Sex Factors | 1 | 2003 | 1715 | 0.040 |
Why?
| | Metal Nanoparticles | 1 | 2018 | 75 | 0.040 |
Why?
| | Cell Cycle | 1 | 2019 | 542 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2003 | 1314 | 0.030 |
Why?
| | DNA | 1 | 2003 | 1352 | 0.030 |
Why?
| | Morbidity | 1 | 2017 | 280 | 0.030 |
Why?
| | Global Health | 1 | 2017 | 287 | 0.030 |
Why?
| | Disaccharides | 1 | 2014 | 16 | 0.030 |
Why?
| | Microscopy, Polarization | 1 | 2014 | 30 | 0.030 |
Why?
| | Neutrophil Infiltration | 1 | 2014 | 96 | 0.030 |
Why?
| | Mesothelioma | 1 | 2014 | 31 | 0.030 |
Why?
| | Hyperplasia | 1 | 2014 | 163 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2021 | 3881 | 0.030 |
Why?
| | Fruit | 1 | 2014 | 127 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 2014 | 397 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2014 | 470 | 0.020 |
Why?
| | Adenoma | 1 | 2014 | 189 | 0.020 |
Why?
| | Indoles | 1 | 2014 | 304 | 0.020 |
Why?
| | B7-2 Antigen | 1 | 2010 | 25 | 0.020 |
Why?
| | Chemokine CXCL2 | 1 | 2010 | 41 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2014 | 633 | 0.020 |
Why?
| | Coal Ash | 1 | 2007 | 4 | 0.020 |
Why?
| | TNF Receptor-Associated Factor 2 | 1 | 2007 | 8 | 0.020 |
Why?
| | Inhalation | 1 | 2007 | 26 | 0.020 |
Why?
| | Epoxy Compounds | 1 | 2007 | 31 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2007 | 271 | 0.020 |
Why?
| | Carbon | 1 | 2007 | 156 | 0.020 |
Why?
| | Reticulocytes | 1 | 2005 | 16 | 0.020 |
Why?
| | United States | 1 | 2020 | 12176 | 0.010 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2005 | 157 | 0.010 |
Why?
| | Nitric Oxide Synthase | 1 | 2005 | 209 | 0.010 |
Why?
| | Lipid Metabolism | 1 | 2007 | 444 | 0.010 |
Why?
| | Oxidation-Reduction | 1 | 2007 | 923 | 0.010 |
Why?
| | Micronuclei, Chromosome-Defective | 1 | 2003 | 2 | 0.010 |
Why?
| | DNA-Activated Protein Kinase | 1 | 2003 | 11 | 0.010 |
Why?
| | Homozygote | 1 | 2003 | 187 | 0.010 |
Why?
| | Neutrophils | 1 | 2007 | 1176 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 2003 | 591 | 0.010 |
Why?
| | Erythrocytes | 1 | 2003 | 591 | 0.010 |
Why?
| | Apoptosis | 1 | 2003 | 2362 | 0.010 |
Why?
|
|
Bauer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|